Login / Signup

Efficacy and Safety of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Age: The DELIVER Trial.

Alexander PeikertFelipe A MartinezMuthiah VaduganathanBrian Lee ClaggettIan J KulacAkshay S DesaiPardeep S JhundRudolf A de BoerDavid L DeMetsAdrian F HernandezCatherine M ViscoliMikhail Naum KosiborodCarolyn Su Ping LamSanjiv J ShahTsvetana KatovaBéla MerkelyOrly VardenyUlrica WilderängDaniel LindholmMagnus PeterssonAnna Maria LangkildeJohn Joseph Valentine McMurrayScott D Solomon
Published in: Circulation. Heart failure (2022)
gov; Unique identifier: NCT03619213.
Keyphrases
  • ejection fraction
  • heart failure
  • aortic stenosis
  • phase iii
  • study protocol
  • phase ii
  • clinical trial
  • left ventricular
  • acute heart failure
  • atrial fibrillation
  • randomized controlled trial